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Abstract
Background: MicroRNAs are 22 nucleotides long non-coding RNAs and exert their function either by transcriptional or
translational inhibition. Although many microRNA profiles in different tissues and disease states have already been
discovered, only little is known about their target proteins. The microRNA miR-155 is deregulated in many diseases,
including cancer, where it might function as an oncoMir.
Methodology/Principal Findings: We employed a proteomics technique called ‘‘stable isotope labelling by amino acids in
cell culture’’ (SILAC) allowing relative quantification to reliably identify target proteins of miR-155. Using SILAC, we identified
46 putative miR-155 target proteins, some of which were previously reported. With luciferase reporter assays, CKAP5 was
confirmed as a new target of miR-155. Functional annotation of miR-155 target proteins pointed to a role in cell cycle
regulation.
Conclusions/Significance: To the best of our knowledge we have investigated for the first time miR-155 target proteins in
the HEK293T cell line in large scale. In addition, by comparing our results to previously identified miR-155 target proteins in
other cell lines, we provided further evidence for the cell line specificity of microRNAs.
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Introduction
MicroRNAs (miRNAs, miRs) are endogenous, non-coding,
single-stranded RNA molecules of about 22 nucleotides that
regulate gene expression at the post-transcriptional level [1]. A
total of 721 different miRNAs are known so far in humans
(miRBase, release 14), and it is assumed that they influence around
60% of protein-coding genes [2], affecting almost every cellular
process [3]. Mature miRNAs are incorporated into the RNA
Induced Silencing Complex (RISC), which guides them to the
appropriate mRNAs [4]. This interaction results in either the
degradation of the mRNA or the inhibition of protein translation
[5–16]. In the latter case, possible points of action are the initiation
[8,9,10] or elongation step [11] of protein translation. The
changes at the protein level are often subtle, leading to the
proposed function of microRNAs as rheostats [17].
High proteome coverage and sensitivity are necessary for large
scale microRNA target protein detection. A method called ‘‘stable
isotope labelling by amino acids in cell culture’’ (SILAC) has
emerged as a powerful approach for quantitative proteomics in the
field of microRNA target identification in cell culture models
[5,7,16,18]. In the SILAC approach, different cell populations are
metabolically labelled to saturation with either light or heavy
isotopic amino acids. The isotopically labelled proteins are
subsequently resolved, identified and quantified by mass spectro-
metric analysis [19].
For a few target proteins, cell line specificity of microRNA
action has been shown [20]. Unfortunately, due to the fact that the
majority of large scale quantitative proteomic data for miRNA
target protein detection were performed in HeLa cells [5,7,18],
few conclusions can be drawn regarding target proteins in other
cell lines.
In this paper, we focus on human microRNA 155 (hsa-miR-155),
whichisknown to influencemanydiseasesand is assumed to function
as an oncoMir in cancer [21]. MiR-155 is derived from a non-coding
RNA transcribed from the B-cell Integration Cluster (BIC) located on
chromosome 21 [22]. In contrast to the considerable knowledge
concerning the deregulation of miR-155, only a few target proteins
have been validated for miR-155 so far [21].
In order to identify miR-155 targets with large scale proteomic
techniques, we analysed HEK293T cells overexpressing miR-155
using the SILAC method. To address the issue of cell line
specificity, we compared our data with recently published SILAC
data of miR-155 targets in HeLa cells [5]. In addition, we
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22146bioinformatically examined the influence of the identified target
proteins on biological processes using functional annotation
enrichment analysis.
Materials and Methods
Cloning
In order to over express miR-155, we cloned a 165 bp fragment
of the BIC gene containing the miR-155 sequence into the EcoRI-
XhoI site of the pCMX-PL1 vector (pCMX-miR-155), using the
primer pair found in Table S1. The pCMX-PL1 vector was a
generous gift of Dr. Roland Schu ¨le (Women’s Hospital and Center
for Clinical Research, Medical School Freiburg, Germany).
Luciferase sensor constructs were generated by cloning full
length 39UTRs containing the predicted miR-155 binding site into
a pMIR-REPORT vector (Ambion, Lincoln, USA) using the
primers found in Table S1.
Cell culture and transfection
For SILAC analysis, SILAC D-MEM media supplemented with
10% dialyzed FBS and either 100 mg/L
12C6-L-arginine and
12C6- L-lysine or
13C6-L-arginine and
13C6-L-lysine (Invitrogen
Corporation, Carlsbad, USA) as well as 200 mg/L
12C5-L-proline
(Promega Corporation, Madison, USA) were used [23].
HEK293T cells were serially passaged (2610
6 cells/10 cm dish)
and grown for five doublings to ensure full incorporation of
labelled amino acids. Subsequently, the cells were transfected with
either 2 mg of the pCMX-miR-155 construct or the empty
plasmid. The cells were harvested 48 h after transfection and
counted using a cell counter (Vi-CELL XR; Beckman Coulter,
Fullerton, USA). Aliquots of cells were mixed in a one to one ratio,
washed two times with ice-cold phosphate-buffered saline (PBS),
shock-frozen in liquid nitrogen for storage at 280uC. A technical
and biological replicate of the same experiment was done with
reverse labelled samples.
For all other transfection assays, HEK293T cells (5610
4/24
well plate) were cultured at 37uC and 10% CO2 in D-MEM
medium supplemented with 100 units/mL penicillin, 100 mg/mL
streptomycin (Invitrogen, Carlsbad, USA) and 10% fetal bovine
serum (FBS) (Biochrom, Berlin, Germany). Cells were transfected
with the respective vector plasmid (see below) using TransIT LT1
transfection reagent (Mirus Bio LLC, Madison, USA) according to
the manufacturer’s instructions. Cells were harvested 48 h after
transfection.
Small RNA preparation and control of miR-155
expression
For verification of miR-155 overexpression, small RNAs were
extracted using a miReasy Kit (Qiagen, Hilden, Germany).
Quantification of miRNA expression was performed using the
TaqMan microRNA Assay Kit (Applied Biosystems, Foster City,
USA) following the manufacturer’s instructions. Each sample was
analysed in triplicate using an ABI PRISM 7700 quantitative PCR
apparatus (Applied Biosystems, Foster City, USA). The expression
values were normalized against the small housekeeping RNAs
RNU-6B and RNU-66. A standardized reference of total RNA
(Stratagene, La Jolla, USA) was used for standard curve
normalization.
Cell lysis and determination of protein concentration
Frozen cell pellets were lysed using RIPA buffer (50 mM Tris-
HCl pH 7.5; 150 mM NaCl; 1% Triton X-100; 0.5% Na-
deoxycholate; 0.1% SDS; 10 mM N-ethylmaleimide, supplement-
ed with mini complete EDTA-free protease inhibitor cocktail
tablet (Roche Diagnostics, Mannheim, Germany) [24]. Protein
concentration of supernatants was measured by 2D Quant Kit
(GE Healthcare Bio-Sciences, Uppsala, Sweden).
SDS-PAGE, tryptic digestion and mass spectrometric
analysis
Equal amounts of protein (100 mg) of each forward and reverse
labelled sample were precipitated using the chloroform/methanol
method [25] and separated on a 4–12% SDS polyacrylamide gel
(NuPAGE Novex Bis-Tris Gel; Invitrogen Corporation, Carlsbad,
USA) following the manufacturer’s instructions. The entire lanes
were cut to get 26 gel slices. Tryptic digestion and extraction were
performed as previously described [26] with adaption to the
volume of the gel plugs. After extraction, the samples were vacuum
dried and then dissolved in 0.1% TFA.
Half of the sample was used for nanoHPLC-ESI-MS/MS
analysis using a LC Packings Ultimate (Dionex Corporation,
Sunnyvale, USA) and a LTQ Orbitrap XL (Thermo Fisher
Scientific, Waltham, USA). A Reprosil-PUR C18-AQ, 3 mm,
150060.075 mm column (Dr. Maisch HPLC GmbH, Ammer-
buch-Entringen, Germany) and a gradient ranging from 14 to
86% MeCN (in 0.1% FA and HPLC-H2O) over 90 min was used
for nanoHPLC. Electrospray ionisation was achieved by using a
PicoTip Emitter Silica Tip (New Objective, Woburn, USA) and a
spray voltage of 1.7 kV. Data dependent acquisition using
Xcalibur 2.0.6 (Thermo Fisher Scientific, Waltham, USA) was
performed by one FTMS scan with a resolution of 60000 (m/z
400) and a range from 370 to 2000 m/z and 6 MS/MS scans of
the most intense precursor ions in the ion trap.
Protein identification and quantification of MS data
For identification and quantification of peptides and their
respective proteins, MaxQuant 1.0.13.13 [27] was used with the
human IPI database (version 3.65; www.ebi.ac.uk/IPI) and
Mascot 2.2.04 (Matrix Science, London, UK). Standard settings
were used for MaxQuant [28], except that the filtering of labelled
amino acids was prohibited and protein groups with at least one
ratio count (evidences of different peptides, charge states or
measurements in replicate) were considered. As identified, all
protein groups with a false discovery rate below 1%, without
contaminants and decoy entries as well as groups without ‘‘only
identified by site’’ were chosen. Quantified protein groups were all
identified ones with at least three ratio counts. Finally, as regulated
protein groups, the quantified ones with a ‘‘significance B’’ value
(indicating whether a ratio is significantly different from the
distribution of all protein ratios; binned into groups by intensity) of
less than 0.01 and a variability of less than 50% were considered.
Information on all quantified proteins which are down- and
upregulated is listed in Table S2 and S3.
Western blot analysis
For Western blotting, protein extracts of non-SILAC labelled
HEK293T cells transfected with 0.45 mg pCMX-miR-155 or the
empty vector were prepared, 10 or 20 mg of protein lysates were
precipitated and separated by SDS-PAGE as described above.
Tank blotting was performed using the XCell II Blot Module
(Invitrogen Corporation, Carlsbad, USA) according to the
manufacturer’s instructions. For immune staining, ECL Plex
(GE Healthcare Bio-Sciences, Uppsala, Sweden) was employed
using CyDye coupled secondary antibodies in conjunction with the
primary antibodies as stated in Table S1. Blots were scanned using
a Typhoon 9410 scanner (GE Healthcare Bio-Sciences, Uppsala,
Sweden) and the instructions described in the ECL Plex manual.
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(http://rsb.info.nih.gov/ij/) was used. The intensity values of the
target protein signals were normalized to the intensity value of
GAPDH as a housekeeping protein.
qRT-PCR of potential miR-155 targets
HEK293T cell were transiently transfected with either 0.45 mg
of the pCMX-miR-155 construct or the empty vector. MicroRNA
containing total RNA was prepared using the miReasy RNA
isolation kit (Qiagen, Hilden, Germany). DNase 1 predigestion
and random primed first strand synthesis was performed on 2 mg
of the total RNA using a slight modification of the SuperscriptII
First Strand Synthesis protocol (300 ng random hexamers,
RNaseH treatment eliminated, 2 mg of T4 gene 32 protein (single
stranded DNA binding protein added; Invitrogen Cooperation,
Carlsbad, USA). Two microliter of each cDNA sample was
analysed in triplicate with the ABI PRISM 7900HT (Applied
Biosystems Inc, Foster City, USA) using Absolute SYBR Green
ROX Mix (ABgene, Hamburg Germany) according to the
manufacturer’s instructions. Primers for qRT-PCR analysis were
designed using the Universal ProbeLibrary Assay Design Center
(www.roche-applied-science.com), and possible transcript variants
were considered. The primers used for analysis, as well as the two
endogenous housekeeping genes (PGK1, DCTN2) used as internal
standards, are found in Table S1. Cycling conditions for the assay
were 50uC, 2 min; 95uC, 15 min; thereafter 40 cycles of 95uC,
15 sec, 60uC, 1 min; thereafter 95uC, 15 sec; 60uC, 15 sec; 95uC,
15 sec. The relative quantification of the RNA of interest in
comparison with the housekeeping genes was calculated by using
standard curves for each gene.
Luciferase reporter assay
The pMIR-REPORT luciferase sensor constructs (5 ng) were
co-transfected with a TK renilla expression plasmid (45 ng,
Promega, Madison, USA) and pCMX-miR-155 (450 ng) into
HEK293T cells using TransIT LT1 transfection reagent as
described above (Mirus Bio LLC, Madison, USA). As a negative
control, HEK293T cells were co-transfected with an empty
pCMX vector (450 ng) instead of the pCMX-miR-155. The cells
were harvested and lysed at 48 h post-transfection. Luciferase
signals were measured using a standard dual luciferase buffer
system [29] on a Mithras luminescence reader (Berthold
Technologies, Bad Wildbad, Germany). Each sample was
measured in triplicate and six assays per sample were performed.
Mapping of prediction algorithm data
Target genes for miR-155 were predicted using TargetScan
v5.1 [2,30,31], RNA22 59UTR, 39UTR and CDS [32],
MicroCosm Version 5 [33] and DIANA-microT v3.0 [34]. The
5 top IPI IDs of the SILAC quantified proteins were mapped by
BRM [35] using their Ensembl gene IDs, Ensembl transcript IDs
or HGNC gene symbols (ENSEMBL 56 Genes (Sanger UK)
Homo sapiens genes (GRCh37)) using the cross references
obtained by the web interface of BioMart [36].
Identification of seed sequence matches
The 8mer (UUAAUGCU), 7mer-A1 (UUAAUGC) and 7mer-
m8 (UAAUGCU) seed sequences of miR-155 were used to search
(FuzzNuc, www.emboss.org) for complete complementary in the
59UTR, CDS and 39UTR of the proteins identified as
upregulated, unregulated and downregulated in SILAC quantifi-
cation. Thereafter, the TOP IPI identifier was used to obtain the
corresponding ENST identifiers using the web interface of
BioMart [36] (ENSEMBL 56 Genes (Sanger UK) Homo sapiens
genes (GRCh37)). The sequences of the 59UTR, CDS and 39UTR
were acquired from the human Ensembl database (www.ensembl.
org) using Ensembl API 52.
Functional annotation clustering
For functional annotation clustering, the beta version of
DAVID 2008 was used [37,38]. The TOP IPI IDs of the
downregulated protein groups were compared against all quan-
tified protein groups of the SILAC experiment as background.
The functional annotation clustering was conducted using all gene
ontology annotated biological processes at standard settings.
Results
Detection of miR-155 regulated proteins by SILAC
In order to detect miR-155 regulated proteins, we ectopically
expressed miR-155 in HEK293T cells and compared the effects at
the protein level by quantitative proteomics using SILAC.
The level of miR-155 was manipulated by overexpressing miR-
155 under the control of a viral promoter using the pCMX vector
system, which resulted in a ca. 1000 fold overexpression when
compared to the low endogenous level of miR-155 in HEK293T
cells containing the empty vector controls as determined by qRT-
PCR (see Figure S1). The total proteomic analysis workflow is
depicted in Figure 1.
Using the SILAC approach, we could identify a total of 3148
protein groups and quantified 2434. Eighty-eight protein groups
were differentially expressed; whereof 42 were upregulated and 46
downregulated (information on down- and upregulated proteins is
given in Table S2 and S3). In addition details on five selected
proteins and their respective peptides are listed in Table S4). The
downregulation of the potential miR-155 target proteins ranged
from 0.58 to 0.85 fold (18 to 72% downregulation) with an average
value of 0.76 (32%). Figure 2 exemplifies a downregulated protein,
KIF11 (A), an unaffected protein, GAPDH (B) and an upregulated
protein, DHFR (C). These results reveal a set of novel miR-155
regulated target proteins in HEK293T cells.
Western blot analysis of downregulated proteins
To validate the miR-155 targets detected by SILAC at the
protein level, we analysed their regulation by quantitative Western
blot analysis using the ECL Plex system on four biological
replicates, independent of the SILAC analysis. For Western blot
analysis, we selected five proteins using 3 criteria: only positive by
seed sequence matches (KIF11), positive by prediction methods
and seed sequence matches (CKAP5), and neither positive by seed
sequence matches nor by prediction methods (UBE2C, RAN-
GAP1, and KPNA2). The results of the five tested targets, KIF11,
UBE2C, RANGAP1, KPNA2 and CKAP5 are shown in Figure 3
A. It was confirmed that all five proteins showed a lower
expression which was statistically significant for CKAP5 (p,0.01,
see also Figure S2) and KIF11 (p,0.05). A high correlation of fold
changes obtained by SILAC versus fold changes obtained by
Western blot analysis was seen (see Table 1), and allowed a
verification of our SILAC quantification.
qRT-PCR analysis of genes of downregulated proteins
To compare miR-155 regulatory effects at the protein level with
those at the mRNA level, we conducted qRT-PCR analysis for the
genes of the five proteins determined by SILAC and verified by
Western blot analysis. No downregulation of the tested genes was
seen at the mRNA level (see Figure 3 B). This result indicated that
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predominantly via inhibition of protein translation.
Binding of miR-155 to putative targets
We compared bioinformatically the complete set of 46 potential
miR-155 targets using different prediction algorithms (RNA22
CDS, 39UTR, 59UTR; DIANA microT, TargetScan and
MicroCosm) and analysed the seed sequence matches (8mer,
7mer-A1 and 7mer-m8) of miR-155 in the 59UTR, CDS and
39UTR sequences of our targets. The detection of CKAP5 by the
prediction algorithm DIANA microT, TargetScan, RNA22 and
the seed sequence matches 7mer-A1 in the 39UTR supported the
luciferase reporter assay result (see Figure 4). Beside the binding of
miR-155 to the 39UTR of CKAP5, there was also a putative
binding site in the CDS region indicated by RNA22-CDS and one
8mer seed sequence match (Table 1). For KIF11 there was no
indication for 39UTR binding by prediction algorithms or seed
sequence matches, and no 39UTR binding was detected by
luciferase reporter assays. In contrast, a 7mer-A1 seed sequence
match for the CDS region (see Table 1) was detected. In total, 15
out of the targeted proteins have at least one putative miR-155
binding site, as identified by bioinformatic analysis.
Next, we analysed the binding of miR-155 to the mRNA
sequences of our identified target set. Luciferase reporter assays
using the 39UTR sequences of KIF11, CKAP5 and IKBKE were
performed. IKBKE served as a positive control (see Figure 4),
since miR-155 39UTR sequence binding was previously reported
[39]. For KIF11 and CKAP5, regulation was detected at the
protein level by SILAC, as well as by Western blot analysis, but
only the 39UTR region of CKAP5 is targeted by miR-155 using
luciferase sensor constructs (see Figure 4). Table 1 summarized the
data for the protein level, mRNA level and target sequence
binding for all significant, differentially expressed proteins
analysed.
Functional annotation to elucidate the role of miR-155
target proteins
To gain further insight into the possible biological role of the 46
target proteins, regulated by miR-155, a bioinformatic analysis
using the DAVID2008 functional analysis software package was
performed [37,38]. We used the functional annotation clustering
approach, which reduces the redundancy in annotation by
grouping similar annotations consisting of similar sets of proteins.
In Table 2, the most significant functional gene ontology (GO)
annotation cluster (cluster 1-cell cycle processes) is shown with its
respective proteins. Twelve of the 46 miR-155 target proteins are
represented in this cluster, including the proteins CKAP5, KIF11,
UBE2C and KPNA2, which were identified as miR-155 target
proteins by SILAC and Western blot analysis in the present study.
CKAP5 has been identified as a direct target of miR-155 and
PCM1, KIF11, RBM4 and TUBA1C are putative direct targets of
miR-155, due to their detection by prediction algorithms or seed
sequence matches. Further clusters include, among others,
stimulus response and RNA processing. The complete DAVID
analysis is found in Supplementary Table S5.
Discussion
MicroRNA research is currently focusing on the identification
of new miRNAs [40], the elucidation of their relative expression
levels [41], their functional effects in diseases [42] and their
therapeutic implications [43]. The missing link is often the
identification of microRNA targets and their biological functions.
So far, miRNA target identification is restricted, because
microRNAs can exert their effects at either the protein or mRNA
level, and the degree to which each can occur in a specific tissue is
still a matter of debate. In addition, large scale quantitative
proteomic studies have only been conducted using a limited
number of miRNAs and cell lines [5–7,15,16,18].
This study was performed to identify miR-155 target proteins in
HEK293T cells using quantitative proteomics and to connect these
data to functional annotations. A 48 hour time period after
transfection was used for the analysis due to the strong miR-155
expression found during this time. Forty-six potential miR-155 target
proteins were identified in HEK293T cells using the SILAC
approach upon miR-155 overexpression, and five selected targets
were further confirmed by quantitative Western blot analysis. The
changes of protein expression weresubtle, which is inagreement with
the hypothesis that single miRNAs act as rheostats by fine tuning
protein abundance [18]. Although all five of the proteins analyzed by
Western blot were downregulated to a certain degree, only KIF11
and CKAP5 passed statistical analysis (Figure 3). This might mean
that only strongly deregulated proteins show statistical relevance
under the conditions used in these experiments. We also compared
Figure 1. Experimental setup of SILAC quantification.
doi:10.1371/journal.pone.0022146.g001
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PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e22146Figure 2. Examples of SILAC quantified peptides. The relative abundance (y-axis) is shown for SILAC peptide pairs and their m/z (mass to
charge ratio) values (x-axis). For each peptide the sequence is displayed and labelled amino acids are marked by an asterisk (*). The slice number of
the SDS-PAGE gel, retention time (RT) in minutes of the peptide in the C18-RP nanoHPLC run and the charge state (z) are also depicted. All peptides
have mass shifts of 6.02 Da per labelled amino acid. A. KIF11, as an example for a downregulated protein by miR-155 overexpression, is highlighted
by two peptides. Both peptides have a higher relative abundance for the heavy labelled form. B. For GAPDH both peptides display a fairly equal
relative abundance. C. DHFR has a higher relative abundance for the light labelled form due to miR-155 overexpression.
doi:10.1371/journal.pone.0022146.g002
Figure 3. Western blot analysis and qRT-PCR analysis of five selected target proteins. The protein levels A or mRNA levels B of the miR-
155 overexpression (HEK293T pCMX miR-155) are compared to the control (HEK293T pCMX empty). The values of the controls are set to 1. The
standard bars show the standard deviation between the four A or three B biological replicates. *: Student’s t-test,0.05; **: Student’s t-test,0.01.
doi:10.1371/journal.pone.0022146.g003
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22146Table 1. Potential downregulated miR-155 target proteins in HEK293T cells detected by SILAC with supportive data (Western blot
analysis, qRT-PCR, miRNA binding).
Protein level
mRNA
level miR-155 binding to mRNA sequences
HGNC symbol
1 SILAC
2
Western
blot
3 qRT-PCR
4
Luciferase
reporter assay
5
Prediction
algorithms
6 Seed sequence matches
7
IMP3 0,579 - - - n.d n.d.
MRFAP1 0,594 - - - n.d. 39UTR7mer-A1
CENPE 0,623 - - - n.d. n.d.
PCM1 0,634 - - - n.d. CDS 7mer-m8
HMGCS1 0,638 - - - RNA22-CDS 39UTR 8mer
MAN2B1 0,644 - - - n.d. n.d.
KIF11 0,675 0.7* 1.07 1.16 n.d. CDS 7mer-A1
TNPO3 0,677 - - - n.d n.d.
FAM115B 0,699 - - - n.d. CDS 7mer-A1, CDS 7mer-m8
39UTR
UBE2C 0,742 0.84 0.95 - n.d. n.d.
POP7 0,743 - - - n.d n.d.
SRXN1 0,744 - - - n.d. 39UTR 7mer-m8
MAPK14 0,745 - - - n.d. n.d.
GPS1 0,746 - - - n.d. n.d.
GEMIN4 0,747 - - - n.d. 39UTR 7mer-m8
KPNA2 0,748 0.9 1.08 - n.d. n.d.
SSR1 0,75 - - - RNA22-39UTR 39UTR 7mer-A1
NOB1 0,751 - - - n.d. n.d.
RBM4 0,754 - - - n.d. n.d.
COPS3 0,757 - - - n.d. 39UTR 7mer-A1
TIMM17A 0,764 - - - n.d. n.d.
GIGYF2 0,769 - - - n.d. CDS 7mer-A1
BAG6 (BAT3) 0,774 - - - n.d. n.d.
HSPBP1 0,778 - - - n.d. n.d.
HSPA1A 0,778 - - - n.d. n.d.
DNAJA1 0,779 - - - n.d. n.d.
USP14 0,78 - - - n.d. 39UTR 7mer-m8
AASDHPPT 0,787 - - RNA22-CDS. n.d.
GTF3C5 0,787 - - - n.d. n.d.
RANGAP1 0,788 0.91 1.04 - n.d. n.d.
METAP1 0,792 - - - n.d. n.d.
EIF1 0,796 - - - n.d. n.d.
CSDE1 0,798 - - - n.d. n.d.
RPL39 0,8 - - - n.d. n.d.
TUBA1C 0,815 - - - n.d. CDS 7mer-A1
HEATR1 0,817 - - - n.d. n.d.
SRRM2 0,817 - - - n.d. n.d.
ABCF2 0,818 - - - n.d. n.d.
RBM3 0,821 - - - n.d. n.d.
CKAP5 0,835 0.74** 0.93 0.65* RNA22-CDS DIANA microT
Targetscan
CDS 8mer, 39UTR 7mer-A1
DDX5 0,84 - - - n.d. n.d.
DDX3X 0,843 - - - n.d. n.d.
PDCD5 0,843 - - - n.d. n.d.
EIF4A1 0,843 - - - n.d. n.d.
RPS14 0,844 - - - n.d. n.d.
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targets (see Figure 3). These results support the view that the
translational inhibition of miRNAs might be a major mechanism of
protein downregulation [5,6,7]. However, our choice of a 48 hour
time period for measurement may have increased the number of
proteins indirectly modulated by miR-155, resulting in the
production of more proteins not containing seed sequences.
The view that microRNAs might exert their effects mainly by
translational inhibition is quite controversial. Several authors have
shown an inverse correlation between microRNA modulation and
mRNA expression in genes containing putative microRNA target
sequences [12–14]. More recently, Guo et al. [15] performed large
scale sequence analysis of both total mRNA and ribosome bound
mRNA transcripts in, among others, miR-155 overexpressing
HeLa cells, correlated these results to protein data determined by
SILAC analysis from a previous miR-155 overexpression study [5]
and confirmed that an inverse correlation existed between
microRNA modulation and gene expression. In addition, in this
study, comparison of genes containing miR-155 targets deter-
mined by bioinformatic analysis showed little decrease in
ribosomally bound genes when compared to total mRNA,
suggesting that translational inhibition was not the main
mechanism in the regulation of these genes.
In contrast, several other studies have shown that specific
microRNAs inhibit either the initiation or elongation step of
protein translation [8,44,45]. On a larger scale, analysis of miR-21
overexpressing MCF7 breast cancer cells by expression microarray
and protein analysis using an iTraq based proteomics strategy
showed no strong correlation between mRNA and protein
expression [6]. Recently, a similar study of miR-143 overexpres-
sion in a pancreatic carcinoma cell line from the same laboratory
using microarray- and SILAC analyses gave similar results [16].
The interaction of miRNAs with their target mRNA sequences
is not completely understood. Target prediction algorithms try to
Protein level
mRNA
level miR-155 binding to mRNA sequences
HGNC symbol
8 SILAC
9
Western
blot
10 qRT-PCR
11
Luciferase
reporter assay
12
Prediction
algorithms
13 Seed sequence matches
14
RPS8 0,849 - - - n.d. n.d.
aHGNC gene symbols (www.genenames.org);
bfold change miR-155/pCMX;
cRNA22 CDS, 39UTR, 59UTR; DIANA microT, TargetScan, MicroCosm;
dSeed sequence (8mer, 7mer-A1, 7mer-m8) matches in the different mRNA regions (59UTR, CDS, 39UTR); -: not tested; n.d.: not detected;
*Student’s t-test below 0,05;
**Student’s t-test below 0,01.
doi:10.1371/journal.pone.0022146.t001
Table 1. Cont.
Table 2. Functional annotation of potential miR-155 target proteins in HEK293T cells.
CKAP5 KIF11 UBE2C CENPE KPNA2 PCM1 TUBA1C RBM4 TIMM17A RPS14 GPS1 MAPK14
Microtubule-based process X XXXXXX
Centrosome organization X X X
Microtubule organizing center
organization
XX X
Microtubule cytoskeleton
organization
XXX X
M p h a s e XXXXX
Nuclear division X X X X
Mitosis X X X X
M phase of mitotic cell cycle X X X X
Organelle fission X X X X
Cell division X X X X
Cytoskeleton organization X X X X
Cell cycle X XXXX X X
Mitotic cell cycle X XXXX
Cell cycle phase X XXXX
Cell cycle process X XXXX
Organelle organization X X X X X X X
Cellular component
organization
XXXX XXXXX
doi:10.1371/journal.pone.0022146.t002
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matches, thermodynamics, sequence conservation or a combina-
tion of these) [17]. It was shown that, besides the most frequent
39UTR binding, also the 59UTR binding [46,47] or binding to the
CDS region [47] must be considered.
We, therefore, examined potential miRNA targets identified by
large scale proteomics for their miRNA binding in the CDS and
59UTR by using the RNA22 algorithm [32] and seed sequence
matches in these regions (see Table 1 and 3). For several target
proteins, the RNA22 algorithm or seed sequence matches
indicated a binding of miR-155 in the CDS, which is in agreement
with the high percentage of miRNA binding sites in CDS in a
recently published Argonaut Co-IP mRNA-miRNA interaction
screen [48].
We found that overexpression of miR-155 leads predominantly to
changes in proteins associated with the cell cycle (Table 2), which was
also shown previously by the miR-155 target protein TP53INP1 [49]
and could now be extended and linked to new cell cycle mediators.
For example, CKAP5, verified as a primary miR-155 target protein
by luciferase reporter assay in this study, plays a role in spindle pole
integrity and is controlled by Aurora-A which is one of the major
checkpoints of the cell cycle [50]. The decrease of KIF11 can inhibit
proliferation, increase apoptosis rate and alter the expression of cell
cycle regulating proteins like survivin and Aurora-A [51]. It has also
been shown that KIF11 inhibits the destruction of cyclin A and B,
Table 3. Potential upregulated miR-155 target proteins in HEK293T cells detected by SILAC with prediction algorithms and seed
sequence matches.
HGNC symbol
1 SILAC
2
Prediction algorithms and
seed sequence matches
34 HGNC symbol
5 SILAC
6
Prediction algorithms and
seed sequence matches
78
SMC1A 1,133 CDS 7mer-A1 LMNA 1,227 n.d.
C8orf62 1,141 n.d. SUCLG2 1,234 39 UTR 7mer-A1
HIST1H1C 1,146 n.d. PSAP 1,235 n.d.
LMNB1 1,149 n.d. CYP51A1 1,256 n.d.
GARS 1,154 n.d. SAMM50 1,27 n.d.
HDGF 1,158 n.d. CRABP2 1,277 n.d.
CDC37 1,165 39UTR-7mer-m8 PAPSS1 1,278 n.d.
CA2 1,167 n.d. TMPO 1,302 CDS 7mer-A1
PWP2 1,176 n.d. PSIP1 1,308 n.d.
PYCR1 1,178 n.d. AMOT 1,328 n.d.
LMNB2 1,189 n.d. CHCHD2 1,365 n.d.
DARS2 1,191 n.d. DPYSL2 1,369 n.d.
ACSL3 1,198 CDS 7mer-A1, 39UTR 7mer-m8 TRIO 1,371 CDS 8mer
CLIC4 1,203 CDS 7mer-A1 CTH 1,436 n.d.
RFC3 1,205 n.d. DHFR 1,437 CDS 7mer-A1
DDX52 1,206 CDS 7mer-m8 H1FX 1,439 n.d.
ALDH7A1 1,207 n.d. XPNPEP1 1,528 CDS 8mer
DYNC1I2 1,216 n.d. EMD 1,62 n.d.
NDUFS1 1,218 n.d. CABC1 1,654 n.d.
TYMS 1,221 n.d. PCK2 1,701 n.d.
9
TFB1M 1,222 n.d. PDCD4 1,71 39UTR 8mer
10
aHGNC gene symbols (www.genenames.org);
bfold change miR-155/pCMX;
cAnalyzed using RNA22 CDS, 39UTR, 59UTR; DIANA microT, TargetScan, MicroCosm;
dSeed sequence (8mer, 7mer-A1, 7mer-m8) matches in the different mRNA regions (59UTR, CDS, 39UTR);
eRN22-CDS positive;
fRNA22-39-UTR positive; -: not tested; n.d.: not detected; *:
doi:10.1371/journal.pone.0022146.t003
Figure 4. Luciferase reporter assays of the 39UTR regions of
KIF11, CKAP5 and IKBKE. The average relative light units (RLU) of six
biological replicates are compared between miR-155 overexpression
(HEK293T pCMX miR-155) and control (HEK293T pCMX empty). *:
Student’s t-test,0.05.
doi:10.1371/journal.pone.0022146.g004
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blocking the ubiquitin-dependent proteolysis of proteins responsible
for sister chromatid separation [52].
So far, 26 direct miR-155 targets were experimentally validated
[21]. We quantified two of them, namely RHOA and FADD, but
both showed no significant downregulation in HEK293T cells.
RHOA has been validated in NMuMG cells [53] and FADD in
MCF7 cells [39]. This indicates that miRNA targets seem to be
cell line specific, as previously reported for single proteins [20].
Grosshans and Filipowicz suggested a re-analysis of the existing
proteomic data of miRNA target identification with respect to
method reliability by utilization of different approaches [54]. To
compare our data set of miR-155 target proteins in HEK293T
cells with others, we chose the only available large scale
quantitative proteomic data for miR-155 targets, which were
generated in HeLa cells [5]. About 1/3 of the proteins
downregulated in HeLa were also quantified in HEK293T cells
(35 of 100). However, none of these proteins were detected as a
miR-155 target in HEK293T cells. One possible explanation
might be that our experimental approach differed substantially
from the one applied by Selbach et al, 2008. First, we used a vector
system for miRNA overexpression, whereas Selbach et al used
synthetic miRNAs. Synthetic miRNAs have an enhanced stability
and circumvent, in contrast to precursor miRNAs, parts of the
natural biogenesis [55]. It is not known, whether this might
influence miRNA target proteins. Second, the SILAC workflow
itself was different: Selbach et al, 2008 used the so-called pSILAC
approach for pulsed labelling of de-novo synthesized proteins,
whereas we performed the classical SILAC workflow. To
investigate the influence of different workflows, we compared the
pSILAC [5] with the classical approach [7,18]. All three studies
aimed to detect miR-1 targets in HeLa cells by synthetic miRNAs.
The overlap of downregulated proteins is 50% between Vinther et
al, 2006 and Selbach et al, 2008; 25% between Vinther et al, 2006
and Baek et al, 2008 and 18% between Selbach et al, 2008 and
Baek et al, 2008. Thus, the overlap of identified microRNA targets
using different SILAC approaches was substantial. Excluding the
workflow dependency, we demonstrated by comparison of miR-
155 target proteins in HEK293T and HeLa cells the cell line
specificity of the respective microRNA targets. One possible
explanation for the specificity of miRNAs could be the differential
expression of mRNAs and their function as pseudotargets [56].
In summary, we identified novel target proteins of miR-155 in
HEK293T cells and showed that these proteins are predominantly
involved in cell cycle regulation. In addition, this study indicates
that microRNA target proteins seem to be cell line specific to a
larger extent than previously known.
Supporting Information
Figure S1 Relative expression of miR-155. Expression of
miR-155 was measured 48 h after transfection of HEK293T cells
with miR-155 pCMX vector or the empty pCMX vector. Cells
transfected with miR-155 showed a ca. 1000 fold overexpression
compared to the empty vector control.
(TIF)
Figure S2 Western blot image of CKAP5. HEK293T cells
were transiently transfected with miR-155 or empty vector
(pCMX). Four independent biological replicates were analysed.
Secondary antibodies were labelled with CyDyes. Intensities of
GAPDH were used for normalization.
(TIF)
Table S1 List of oligonucleotides for miR-155 overex-
pression construct and for sensor constructs, oligonu-
cleotide sequences for qRT-PCR assay and list of
antibodies used for Western blotting.
(XLS)
Table S2 List of downregulated proteins identified and
quantified by SILAC.
(XLS)
Table S3 List of upregulated proteins identified and
quantified by SILAC.
(DOC)
Table S4 Detailed information on the five proteins
KIF11, UBE2C, RANGAP1, KPNA2 and CKAP5 shown
in Figure 3. Data on identified and quantified peptides are given
as obtained by MaxQuant 1.0.13.13. Only peptides unique to the
respective protein are listed.
(XLS)
Table S5 Functional annotation of potential miR-155
target proteins using the DAVID2008 analysis software.
(XLS)
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